Terry Brady is an accomplished financial executive with extensive experience in various leadership roles. Currently serving as Chief Financial Officer at Elephas since June 2020, Terry previously held the same position at Farcast Biosciences, a diagnostic company aiding oncologists in therapy selection, from June 2019 to June 2020. Earlier experience includes Chief Financial Officer at Freedom Graphic Systems from January 2011 to May 2019, and Partner at Silverman Consulting from July 2005 to September 2012. Terry began the career as a Senior Associate at KPMG from 2002 to 2005. Educational credentials include a BBA and MS in Accounting from the University of Notre Dame - Mendoza College of Business, as well as an MBA in Management, Strategy & Operations from Northwestern University - Kellogg School of Management.
Org chart
Teams
Offices
This person is not in any offices
Elephas
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodalmicroscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.
